Shortly after the shortage ended, a compounding trade group called the Outsourcing Facilities Association filed a lawsuit in a Texas federal court against the FDA, claiming that tirzepatide remains in short supply and that the decision to officially end the shortage is abruptly depriving patients of a much-needed treatment and artificially raising drug prices. Some telehealth companies selling compounded tirzepatide have introduced versions of the medication with other ingredients, including glycine, niacinamide, and other B vitamins
resulting in shift of the oxygen dissociation curve to the left
These peptides work on pathways related to hormone release, tissue repair, and sleep regulation
Recognizing the potential long-term benefits for enrollees cost of coverage, a number of state Medicaid and employee health plans initiated coverage of GLP-1s for weight loss purposes
Despite continuing this routine, her weight progressively increased to 290 lbs
Itching in patients with chronic hand eczema: data from the CARPE Registry